Decay already prevalent at kids’ 1st dental visit
More than 20% of children need restorative treatment by the time of their first dental exam, according to a study published in the Journal of
More than 20% of children need restorative treatment by the time of their first dental exam, according to a study published in the Journal of
CoreBone, a developer of coral-based bioactive bone graft material for dental and orthopedic indications, has raised $3.7 million in an investment round. CoreBone’s coral is
Dental technology company Sonendo has purchased all assets of FluidFile, an Israeli developer of alternative root canal treatments. The transaction primarily consists of a patent
Imaging and lab work helped diagnose a central giant cell granuloma (CGCG) — a rare, benign, aggressive tumor — in a 17-year-old with jaw pain
For nearly 30 years, dentists have successfully used laser technology to solve myriad dental problems. Nevertheless, misconceptions about this technology remain. Here’s my response to
Oral health is having its moment on a global scale. The World Health Organization (WHO) will add fluoride toothpaste, silver diamine fluoride (SDF), and glass
Researchers unearthed a jawbone from the Indonesian island of Sulawesi that belonged to an ancient human with a surprising dental wear pattern, according to an
Dental product and device company Pac-Dent has acquired endodontic manufacturing firm JS Dental Manufacturing. The purchase will expand Pac-Dent’s endodontic portfolio, it said. Pac-Dent was
GC America has released its GC Initial LiSi block, a crystallized lithium disilicate block that doesn’t require firing, according to the company. The block features
Premier Dental is highlighting four new products it said will help dentists be more efficient and improve patient outcomes. The new products are as follows:
A woman spent 35 years with severe pain due to the placement of a temporomandibular joint (TMJ) prosthetic device, and her case illustrates why these
A preemptive low dose of the nonsteroidal anti-inflammatory drug (NSAID) etoricoxib may reduce the need for analgesics after third-molar surgery, based on the results of